From LC interview this morning on the A.U.S.B.I.Z. web channelre...

From LC interview this morning on the A.U.S.B.I.Z. web channel

re Pd1vax high dose cohort
" we already have the next patients lined up so it will be quick"

re what's next to develop it?? ,
" we are already planning a combination study" ... ie. Big Pharma partnership discussions are well and truely underway.

my own opinion, partnership/ licensing deal upfront and milestone fees to Imugene will easily have a face value of a billion US dollars each for both HerVaxx and Pd1 Vaxx based off existing market deals for lesser therapies.

that alone is in excess 50c per share.

sum of the parts.... add em all up.
20_30c combined value for the whole pipeline is just simply absurd .